首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

American Journal Of Therapeutics

American Journal Of Therapeutics杂志,由Lippincott Williams and Wilkins Ltd.出版,于1994年创刊,Bimonthly,出版语言English,ISSN:1075-2765,E-ISSN:1536-3686。

投稿咨询
American Journal Of Therapeutics
American Journal Of Therapeutics
American Journal Of Therapeutics
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
4区
影响因子
3.5
CiteScore
3.4
期刊收录
SCI、SCIE

American Journal Of Therapeutics(中文译名:《美国治疗学杂志》),ISSN:1075-2765,EISSN:1536-3686,是Lippincott Williams and Wilkins Ltd.出版的国际性学术期刊,创刊于1994年,以Bimonthly形式稳定发行,2026年总发文量约34篇。该刊采用非OA开放访问,学科归属为PHARMACOLOGY & PHARMACY。该刊是医学、药学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3.5,2025年期刊CiteScore为3.4,2025年期刊自引率约28.6%,在中科院期刊分区体系中位列医学大类4区,在所属学科领域具备高学术影响力与国际认可度。American Journal Of Therapeutics长期聚焦医学、药学及相关产业的技术应用前沿,平均审稿周期较慢,6-12周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USACHINA MAINLAND、Romania、Kuwait、India、Taiwan、Spain等为核心发文国家与地区;STATE UNIVERSITY OF NEW YORK (SUNY) SYSTEMMAIMONIDES MEDICAL CENTER、NORTHWELL HEALTH、WAYNE STATE UNIVERSITY、WESTCHESTER MEDICAL CENTER、NEW YORK MEDICAL COLLEGE、TRANSYLVANIA UNIVERSITY OF BRASOV等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 134 / 356

62.5

学科:PHARMACOLOGY & PHARMACY SCIE Q3 227 / 356

36.38

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 181 / 352

48.7

学科:PHARMACOLOGY & PHARMACY SCIE Q3 198 / 353

44.05


中国学者近期发文

1
Is GB34-Based Acupuncture Combined With Conventional Rehabilitation More Beneficial for Post-Stroke Lower Limb Motor Recovery? A Systematic Review and Meta-Analysi

Author:Zhuang, Yu-Xin; Ma, Liang-Xiao; Wen, Jing-Si; He, Jia-Ling; Ma, Ling-Hui; Xiu, Jing-Yun; Chen, Meng-Yu

Journal: AMERICAN JOURNAL OF THERAPEUTICS. 2026; Vol. 33, Issue 1, pp. e52-e55. DOI: 10.1097/MJT.0000000000002093

2
Acute Hypervolemic Hemodilution Enhances the Depth of Propofol Anesthesi

Author:Zhang, Chen

Journal: AMERICAN JOURNAL OF THERAPEUTICS. 2026; Vol. 33, Issue 1, pp. e102-e103. DOI: 10.1097/MJT.0000000000001952

3
The Decrease of PD-L1 Expression Affects the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Lung Squamous Cell Carcinom

Author:Yin, Jie; Du, Mingzhan; Gong, Yinhua; Shen, Dan

Journal: AMERICAN JOURNAL OF THERAPEUTICS. 2026; Vol. 33, Issue 1, pp. e105-e107. DOI: 10.1097/MJT.0000000000001965

4
Exploring External Complementary Therapeutic Methods for Knee Osteoarthritis: Implications for Clinical Practic

Author:Yang, Qi; Dong, Jian-Jun; Du, Jiong; Wang, Jing; Li, Yun-Da; Ma, Cheng-Hao; Hong, Hai-Ping

Journal: AMERICAN JOURNAL OF THERAPEUTICS. 2026; Vol. 33, Issue 1, pp. -. DOI: 10.1097/MJT.0000000000001953

5
Omalizumab Treatment for Pregnancy With Refractory Acute Urticari

Author:Deng, Qiancheng; Wu, Yanyan; Wang, Su; Fang, Hong; Qiao, Jianjun

Journal: AMERICAN JOURNAL OF THERAPEUTICS. 2026; Vol. 33, Issue 1, pp. -. DOI: 10.1097/MJT.0000000000001994

6
Effective Treatment of Darier Disease With Abrocitinib Combined and Acitretin Capsules: A Case Repor

Author:Chen, Xiang-Yu; Shi, Bing-Jun

Journal: AMERICAN JOURNAL OF THERAPEUTICS. 2026; Vol. 33, Issue 1, pp. -. DOI: 10.1097/MJT.0000000000001972

7
Efficacy and Safety of Zanubrutinib in B-Cell Malignancies: A Single-Arm Meta-Analysi

Author:Chen, Rongrong; Yu, Shiquan; Liao, Yun; Liu, Jiayue; Huang, Chunlan

Journal: AMERICAN JOURNAL OF THERAPEUTICS. 2026; Vol. 33, Issue 1, pp. -. DOI: 10.1097/MJT.0000000000001872

8
Abrocitinib in the Treatment of Drug Reaction With Eosinophilia and Systemic Symptom

Author:Zhang, ZhiQin; Liu, Juan; Wu, Di; Sun, WeiLing; Yin, ZhiQiang

Journal: AMERICAN JOURNAL OF THERAPEUTICS. 2025; Vol. 32, Issue 3, pp. e284-e286. DOI: 10.1097/MJT.0000000000001865

9
Dupilumab in the Treatment of Severe Atopic Dermatitis With Ocular Complication

Author:Xia, Jiping; Yu, Yan; Zhang, Chengzhong

Journal: AMERICAN JOURNAL OF THERAPEUTICS. 2025; Vol. 32, Issue 3, pp. e307-e308. DOI: 10.1097/MJT.0000000000001839

10
Retrospective Analysis of Therapeutic Efficacy and Prognosis of Neoadjuvant Chemotherapy in Patients With Mid to Low Locally Advanced Rectal Cance

Author:Guo, Qinping; Wang, Kang; Yu, Chao; Yao, Li; Han, Zhenguo

Journal: AMERICAN JOURNAL OF THERAPEUTICS. 2025; Vol. 32, Issue 3, pp. e294-e297. DOI: 10.1097/MJT.0000000000001812


在线咨询

American Journal Of Therapeutics

国际简称:AM J THER参考译名:美国治疗学杂志

年发文量:34 CiteScore:3.4 是否预警:否 Gold OA文章占比:14.66% 研究类文章占比:70.59%

杂志社联系方式:LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621

American Journal Of Therapeutics